Trademark Overview
On Thursday, December 18, 2025, a trademark application was filed for MSK NEOQUAL with the United States Patent and Trademark Office. The USPTO has given the MSK NEOQUAL trademark a serial number of 99555012. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, April 21, 2026. This trademark is owned by Memorial Sloan-Kettering Cancer Center. The MSK NEOQUAL trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Downloadable computer software and computer algorithms for analyzing next-generation sequencing data to identify and predict tumor-specific neoantigens for use in scientific research and medical research in the fields of oncology, immunology, and precision medicine
Medical services; Healthcare services for treating cancer; Hospital services, namely, patient treatment and care; Pharmaceutical prescription formulation being compounding, and dispensing services; Providing medical services in the nature of patient consultations and medical information via telemedicine
Non-downloadable computer software and computer algorithms for analyzing next-generation sequencing data to identify and predict tumor-specific neoantigens for use in scientific research and medical research in the fields of oncology, immunology, and precision medicine; providing scientific research and analysis services in the field of immunology, namely, proprietary methods for analyzing T cell receptor sequencing data for scientific and medical research and health treatment purposes; providing software for analyzing T cell receptor sequences and identifying T cell clonal lineages; bioinformatics services for identifying and tracking T cell populations in connection with monitoring immune response dynamics, endogenous and with therapeutic interventions; research in the biomedical sciences fields, including molecular biology, cell biology, genetics, and immunology; Medical initiative services, namely, research and development services pertaining to the development of cancer vaccines a...
